Loading...
Loading...
India's serum imports from SINGAPORE total $60.9K across 905 shipments from 15 foreign suppliers. M/S. LABCORP DEVELOPMENT (ASIA) PTE leads with $23.1K in import value; the top 5 suppliers together control 91.2% of this origin. Leading Indian buyers include SYNGENE INTERNATIONAL LIMITED. This corridor reflects India's pharmaceutical import demand for serum โ a diversified sourcing base with multiple active suppliers from SINGAPORE.

M/S. LABCORP DEVELOPMENT (ASIA) PTE is the leading Serum supplier from SINGAPORE to India, with import value of $23.1K across 426 shipments. The top 5 suppliers โ M/S. LABCORP DEVELOPMENT (ASIA) PTE, GLOBAL LIFE SCIENCES SOLUTIONS SINGAPORE PTE LTD.,, M/S. ICON LABORATORY SERVICES,, CORDLIFE GROUP LTD, LABCORP DEVELOPMENT (ASIA) PTE LTD โ collectively account for 91.2% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | M/S. LABCORP DEVELOPMENT (ASIA) PTE | $23.1K | 426 | 37.9% |
| 2 | GLOBAL LIFE SCIENCES SOLUTIONS SINGAPORE PTE LTD., | $18.0K | 16 | 29.5% |
| 3 | M/S. ICON LABORATORY SERVICES, | $6.5K | 51 | 10.7% |
| 4 | CORDLIFE GROUP LTD | $5.2K | 27 | 8.5% |
| 5 | LABCORP DEVELOPMENT (ASIA) PTE LTD | $2.8K | 136 | 4.6% |
| 6 | CORDLIFE GROUP LIMITED | $2.1K | 8 | 3.5% |
| 7 | M S LABCORP DEVELOPMENT ASIA PTE | $666 | 74 | 1.1% |
| 8 | M/S. Q SQUARED SOLUTIONS PTE. LTD. | $629 | 32 | 1.0% |
| 9 | M/S. Q2 SOLUTIONS., | $340 | 1 | 0.6% |
| 10 | MS LABCORP DEVELOPMENT (ASIA) PTE | $321 | 61 | 0.5% |
| 11 | Q SQUARED SOLUTIONS PTE. LTD | $204 | 3 | 0.3% |
| 12 | LABCORP DEVELOPMENT ASIA PTE LTD | $202 | 35 | 0.3% |
| 13 | LIFE TECHNOLOGIES HOLDINGS PTE LTD | $184 | 1 | 0.3% |
| 14 | Q SQUARED SOLUTIONS PTE. LTD. | $113 | 1 | 0.2% |
| 15 | M/S. MEDPACE SINGAPORE PTE LTD (MED | $112 | 3 | 0.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SYNGENE INTERNATIONAL LIMITED | $32.0K | 753 | 52.6% |
| 2 | SPINCOTECH PRIVATE LIMITED | $18.0K | 16 | 29.5% |
| 3 | CORDLIFE SCIENCES INDIA PVT LTD | $4.8K | 25 | 7.8% |
| 4 | VEEDA CLINICAL RESEARCH LIMITED | $2.4K | 10 | 4.0% |
| 5 | CORDLIFE SCIENCES INDIA PRIVATE LIMITED | $2.1K | 8 | 3.5% |
| 6 | Syngene International Limited Unit IV BLOCK S 12 | $782 | 87 | 1.3% |
| 7 | CORDLIFE SCIENCES INDIA PVT. LTD. | $419 | 2 | 0.7% |
| 8 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | $184 | 1 | 0.3% |
| 9 | IQVIA RDS (INDIA) PRIVATE LIMITED | $117 | 2 | 0.2% |
| 10 | IQVIA RDS INDIA PRIVATE LIMITED | $82 | 1 | 0.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Serum suppliers from SINGAPORE to India include M/S. LABCORP DEVELOPMENT (ASIA) PTE, GLOBAL LIFE SCIENCES SOLUTIONS SINGAPORE PTE LTD.,, M/S. ICON LABORATORY SERVICES,. The leading supplier is M/S. LABCORP DEVELOPMENT (ASIA) PTE with import value of $23.1K USD across 426 shipments. India imported Serum worth $60.9K USD from SINGAPORE in total across 905 shipments.
India imported Serum worth $60.9K USD from SINGAPORE across 905 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Serum sourced from SINGAPORE include SYNGENE INTERNATIONAL LIMITED, SPINCOTECH PRIVATE LIMITED, CORDLIFE SCIENCES INDIA PVT LTD. The largest buyer is SYNGENE INTERNATIONAL LIMITED with $32.0K in imports across 753 shipments.
The total value of Serum imports from SINGAPORE to India is $60.9K USD, across 905 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
905 Verified Shipments
15 suppliers, 10 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists